相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
Dapeng Sun et al.
CELL DEATH & DISEASE (2022)
Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation
Hua Ding et al.
CANCER CELL INTERNATIONAL (2021)
Cancer-related SRCAP and TPR mutations in colon cancers
Seong Won Moon et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
Katherine A. Giles et al.
CLINICAL EPIGENETICS (2021)
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
Zhongwei Li et al.
CELL DEATH & DISEASE (2021)
LSD1 Promotes Prostate Cancer Cell Survival by Destabilizing FBXW7 at Post-Translational Level
Xu-ke Qin et al.
FRONTIERS IN ONCOLOGY (2021)
The impact of CBP expression in estrogen receptor-positive breast cancer
Wafaa S. Ramadan et al.
CLINICAL EPIGENETICS (2021)
Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer
Apolonia Novillo et al.
FRONTIERS IN ONCOLOGY (2021)
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression
Pablo Oppezzo et al.
FRONTIERS IN ONCOLOGY (2021)
Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study
Yen-Hao Chen et al.
BMC CANCER (2021)
JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1
Qun Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)
TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models
Sherry X. Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma
Didi Yuan et al.
FRONTIERS IN ONCOLOGY (2021)
Misregulation of the expression and activity of DNA methyltransferases in cancer
Isaiah K. Mensah et al.
NAR CANCER (2021)
CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer
Chia-Lo Chang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Yao-Hui Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
Gongmin Zhu et al.
AGING-US (2020)
Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway
Ning-Ning Dang et al.
AGING-US (2020)
Clinicopathologic Characteristics of BRG1-De fi cient NSCLC
Ibiayi Dagogo-Jack et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Polycomb regulation is coupled to cell cycle transition in pluripotent stem cells
Helena G. Asenjo et al.
SCIENCE ADVANCES (2020)
Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Lucia Carril-Ajuria et al.
CANCERS (2020)
CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A
Nuo Xu et al.
BMC CANCER (2020)
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma
Bingqi Ma et al.
BMC CANCER (2020)
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Yuanjun Lu et al.
MOLECULAR CANCER (2020)
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
Jiayu Zhang et al.
CANCERS (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Understanding 'Non-genetic' Inheritance: Insights from Molecular-Evolutionary Crosstalk
Irene Adrian-Kalchhauser et al.
TRENDS IN ECOLOGY & EVOLUTION (2020)
Evidence for germline non-genetic inheritance of human phenotypes and diseases
Liana Senaldi et al.
CLINICAL EPIGENETICS (2020)
ARID2 Chromatin Remodeler in Hepatocellular Carcinoma
Robin Loesch et al.
CELLS (2020)
Tumor mutation burden and JARID2 gene alteration are associated with short disease-free survival in locally advanced triple-negative breast cancer
Xiangmei Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
Xue-ting Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Tet2 at the interface between cancer and immunity
Shuai Jiang
COMMUNICATIONS BIOLOGY (2020)
JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level
Da Huang et al.
CELL COMMUNICATION AND SIGNALING (2020)
Polycomb repressive complex 2 inhibitors: emerging epigenetic modulators
Danishuddin et al.
DRUG DISCOVERY TODAY (2019)
Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling
Xuliang Wang et al.
LIFE SCIENCES (2019)
The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
Debora Kristina Alves-Fernandes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interplay of miR-137 and EZH2 contributes to the genome-wide redistribution of H3K27me3 underlying the Pb-induced memory impairment
Xiaozhen Gu et al.
CELL DEATH & DISEASE (2019)
JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle
Abhinav Adhikari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Boheng Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
Iga Jancewicz et al.
EPIGENETICS & CHROMATIN (2019)
JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer
Ivano Mocavini et al.
CANCER SCIENCE (2019)
Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation
David S. Goerlitz et al.
SCIENTIFIC REPORTS (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature
Raquel A. C. Machado et al.
SCIENTIFIC REPORTS (2019)
Perspectives on Neuroscience and Behavior
[Anonymous]
NEUROSCIENTIST (2018)
Double sword role of EZH2 in leukemia
Sahar Safaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
Charly Ryan Good et al.
CANCER RESEARCH (2018)
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Shaofei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
Lu Gan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
Bayley A. Jones et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Lixin Wan et al.
MOLECULAR CELL (2018)
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
Daniela Magliulo et al.
FRONTIERS IN ONCOLOGY (2018)
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuang-Tai Kuo et al.
CLINICAL EPIGENETICS (2018)
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
Hamza Celik et al.
CANCER CELL (2018)
Polycomb Repressive Complex 2: Emerging Roles in the Central Nervous System
Pei-Pei Liu et al.
NEUROSCIENTIST (2018)
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
Lu Gan et al.
BIOMARKER RESEARCH (2018)
Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
Goro Sashida et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma
Yanxiao Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway
Jian Cao et al.
MOLECULAR MEDICINE REPORTS (2017)
Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7
Xiaofang Chu et al.
MOLECULAR ONCOLOGY (2017)
Propagation of Polycomb-repressed chromatin requires sequence-specific recruitment to DNA
Friederike Laprell et al.
SCIENCE (2017)
The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer
Qiong Wu et al.
EPIGENOMICS (2017)
Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer
Xin-Xing Zhu et al.
ONCOTARGET (2017)
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
Yiping Wen et al.
ONCOTARGET (2017)
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
Qi Zhang et al.
SCIENTIFIC REPORTS (2017)
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Krysta Mila Coyle et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Function of JARID2 in bovines during early embryonic development
Yao Fu et al.
PEERJ (2017)
Molecular architecture of polycomb repressive complexes
Emily C. Chittock et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
Bolag Altan et al.
GASTRIC CANCER (2016)
EZH2 in normal hematopoiesis and hematological malignancies
Laurie Herviou et al.
ONCOTARGET (2016)
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Anna Kazanets et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
Junli Yan et al.
BLOOD (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity
Jae Won Chang et al.
ORAL ONCOLOGY (2016)
Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma
Jisheng Zhang et al.
CELL DEATH & DISEASE (2016)
EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer
Ting Han et al.
ONCOTARGET (2016)
Normal formation of a vertebrate body plan and loss of tissue maintenance in the absence of ezh2
Bilge San et al.
SCIENTIFIC REPORTS (2016)
Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
Adam Collinson et al.
CELL REPORTS (2016)
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
Anne Laugesen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21
Naiara Akizu et al.
OPEN BIOLOGY (2016)
The Role of JARID2 in Normal and Malignant Hematopoiesis
Hamza Celik et al.
BLOOD (2016)
Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2
Sarah A. Kinkel et al.
BLOOD (2015)
Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation
Serena Sanulli et al.
MOLECULAR CELL (2015)
The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin
Merry Gunawan et al.
NATURE IMMUNOLOGY (2015)
Jarid2 Coordinates Nanog Expression and PCP/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development
David Landeira et al.
CELL REPORTS (2015)
Functional role of G9a histone methyltransferase in cancer
Francesco Casciello et al.
FRONTIERS IN IMMUNOLOGY (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
Satoi Nagasawa et al.
PLOS ONE (2015)
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis
Ruggiero Norfo et al.
BLOOD (2014)
Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer
Tatiana Cajuso et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Z. S. Walters et al.
ONCOGENE (2014)
Sorting out functions of sirtuins in cancer
M. Roth et al.
ONCOGENE (2014)
JARID2 Is Involved in Transforming Growth Factor-Beta-Induced Epithelial-Mesenchymal Transition of Lung and Colon Cancer Cell Lines
Shoichiro Tange et al.
PLOS ONE (2014)
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
Goro Sashida et al.
NATURE COMMUNICATIONS (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Interplay between the Cancer Genome and Epigenome
Hui Shen et al.
CELL (2013)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin
Jinsook Son et al.
GENES & DEVELOPMENT (2013)
PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
Hae-Yun Jung et al.
MOLECULAR CELL (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia
Jiali Li et al.
NATURE NEUROSCIENCE (2013)
Epigenetic Inheritance of Disease and Disease Risk
Johannes Bohacek et al.
NEUROPSYCHOPHARMACOLOGY (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Senescence-associated protein p400 is a prognostic marker in renal cell carcinoma
Stephan Macher-Goeppinger et al.
ONCOLOGY REPORTS (2013)
Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations
Hong Wu et al.
PLOS ONE (2013)
EZH2, an epigenetic driver of prostate cancer
Yeqing Angela Yang et al.
PROTEIN & CELL (2013)
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You et al.
CANCER CELL (2012)
IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Hui Yang et al.
CLINICAL CANCER RESEARCH (2012)
PRC2 directly methylates GATA4 and represses its transcriptional activity
Aibin He et al.
GENES & DEVELOPMENT (2012)
EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex
Ji Min Lee et al.
MOLECULAR CELL (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
The Expression Pattern of Polycomb Group Protein Ezh2 During Mouse Embryogenesis
Ningxia Zhu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2011)
Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
Daisy P. F. Tsang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Inactive yet indispensable: the tale of Jarid2
David Landeira et al.
TRENDS IN CELL BIOLOGY (2011)
Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
Rita U. Lukacs et al.
CELL STEM CELL (2010)
Jarid2 and PRC2, partners in regulating gene expression
Gang Li et al.
GENES & DEVELOPMENT (2010)
The Chromatin Remodeling Factor SRCAP Modulates Expression of Prostate Specific Antigen and Cellular Proliferation in Prostate Cancer Cells
Artur Slupianek et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators
David Landeira et al.
NATURE CELL BIOLOGY (2010)
BRD7 is a candidate tumour suppressor gene required for p53 function
Jarno Drost et al.
NATURE CELL BIOLOGY (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Histone modification levels are predictive for gene expression
Rosa Karlic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bmi-1, stem cells and cancer
Lili Jiang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells
Jamy C. Peng et al.
CELL (2009)
Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells
Xiaohua Shen et al.
CELL (2009)
Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus
Hainan Chen et al.
GENES & DEVELOPMENT (2009)
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
Stefan Hinz et al.
JOURNAL OF UROLOGY (2009)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif
Shengjiang Tu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Manching Ku et al.
PLOS GENETICS (2008)
Structural basis of EZH2 recognition by EED
Zhifu Han et al.
STRUCTURE (2007)
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Tarjei S. Mikkelsen et al.
NATURE (2007)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Epigenetic mechanisms and gastrointestinal development
Robert A. Waterland
JOURNAL OF PEDIATRICS (2006)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
JUMONJI, a critical factor for cardiac development, functions as a transcriptional repressor
TG Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
DNA methylation: An alternative pathway to cancer
SA Wajed et al.
ANNALS OF SURGERY (2001)
The Polycomb-group gene Ezh2 is required for early mouse development
D O'Carroll et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mutations truncating the EP300 acetylase in human cancers
SA Gayther et al.
NATURE GENETICS (2000)
分享论文
